381 related articles for article (PubMed ID: 16188896)
1. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
[TBL] [Abstract][Full Text] [Related]
2. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity.
Mundy AL; Haas E; Bhattacharya I; Widmer CC; Kretz M; Hofmann-Lehmann R; Minotti R; Barton M
Cardiovasc Res; 2007 Jan; 73(2):368-75. PubMed ID: 17166491
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide counteracts angiotensin II induced contraction in efferent arterioles in mice.
Patzak A; Kleinmann F; Lai EY; Kupsch E; Skelweit A; Mrowka R
Acta Physiol Scand; 2004 Aug; 181(4):439-44. PubMed ID: 15283756
[TBL] [Abstract][Full Text] [Related]
4. Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.
Liu ZZ; Mathia S; Pahlitzsch T; Wennysia IC; Persson PB; Lai EY; Högner A; Xu MZ; Schubert R; Rosenberger C; Patzak A
Am J Physiol Renal Physiol; 2017 May; 312(5):F908-F916. PubMed ID: 28052871
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
6. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
Helle F; Iversen BM; Chatziantoniou C
Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.
Chatziantoniou C; Boffa JJ; Ardaillou R; Dussaule JC
J Clin Invest; 1998 Jun; 101(12):2780-9. PubMed ID: 9637712
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole.
Wang X; Breaks J; Loutzenhiser K; Loutzenhiser R
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F999-F1006. PubMed ID: 17090779
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of pulmonary arteriolar vasoconstriction to endothelin-1 by inhibition of nitric oxide synthesis in the intact lung.
Roberts AM; Slaaf DW; Joshua IG
Microcirculation; 1998; 5(4):289-98. PubMed ID: 9866120
[TBL] [Abstract][Full Text] [Related]
10. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice.
Hercule HC; Tank J; Plehm R; Wellner M; da Costa Goncalves AC; Gollasch M; Diedrich A; Jordan J; Luft FC; Gross V
Exp Physiol; 2007 Nov; 92(6):1014-22. PubMed ID: 17644703
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide.
Fernandes L; Loiola RA; Tostes RC; Nigro D; Fortes ZB; de Carvalho MH
Peptides; 2005 Dec; 26(12):2458-63. PubMed ID: 16043265
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.
Ramirez R; Chong T; Victorino GP
J Surg Res; 2006 Aug; 134(2):259-64. PubMed ID: 16515797
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
14. AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles.
Patzak A; Lai EY; Mrowka R; Steege A; Persson PB; Persson AE
Kidney Int; 2004 Nov; 66(5):1949-58. PubMed ID: 15496166
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension.
Carlström M; Lai EY; Steege A; Sendeski M; Ma Z; Zabihi S; Eriksson UJ; Patzak A; Persson AE
Hypertension; 2008 May; 51(5):1386-92. PubMed ID: 18391091
[TBL] [Abstract][Full Text] [Related]
16. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL
Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced constrictions are masked by bovine retinal vessels.
Kulkarni PS; Hamid H; Barati M; Butulija D
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):721-8. PubMed ID: 10067976
[TBL] [Abstract][Full Text] [Related]
19. Marked heterogeneity of endothelin-mediated contractility and contraction dynamics in mouse renal and femoral arteries.
Widmer CC; Mundy AL; Kretz M; Barton M
Exp Biol Med (Maywood); 2006 Jun; 231(6):777-81. PubMed ID: 16740998
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1999 Dec; 128(8):1795-803. PubMed ID: 10588936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
